Stocks TelegraphStocks Telegraph
Stock Ideas

CNTA Stock Performance and Key Statistics

NASDAQ : CNTA

Centessa Pharmaceuticals

$39.69
-0.07-0.18%
At Close 4:00 PM
63.35
BESG ScoreESG Rating

stock performance chart

CNTA Fundamental Analysis

Based on recent data, Centessa Pharmaceuticals plc (CNTA) shows an Average True Range (ATR) of 1.23 and an Enterprise Value of 890.97M. Its average trading volume over the past 3 months is 2.62M, indicating liquidity. These fundamental metrics provide insight into CNTA's underlying financial health and market activity.

ATR1.23
Enterprise Value890.97M
Avg Vol (3 Months)2.62M
Avg Vol (10 Days)1.66M

CNTA Technical Analysis Indicators

Centessa Pharmaceuticals plc (CNTA) technical indicators as of June 11, 2026: the SMA 20 is 7.74%, SMA 50 at 9.7%, and SMA 200 at 30.29%. The RSI 14 value is 65.54, suggesting its current momentum. These technical analysis signals help assess CNTA's price trends and potential future movements.

SMA 207.74%
SMA 509.7%
SMA 20030.29%
RSI 1465.54

CNTA Stock Performance Overview

Centessa Pharmaceuticals plc (CNTA) stock performance overview as of June 11, 2026: The 52-week high is $40.26 (currently -12.46% below), and the 52-week low is $11.77 (currently 178.85% above). Over the past year, CNTA's performance is 54.14%, compared to the S&P 500's 9.37% change.

52-Week High40.26
52-Week High Chg-12.46%
52-Week Low11.77
52-Week Low Chg+178.85%
S&P 500 52-Week Chg9.37%

Centessa Pharmaceuticals plc (CNTA) Historical Stock Performance

According to market data, Centessa Pharmaceuticals plc (CNTA) stock's recent performance metrics show that over the last month, CNTA is -8.25%, with a Year-to-Date (YTD) performance of -8.36%. Over the past year, the stock has seen a 54.14% change. These figures summarize CNTA's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High39.8839.9240.2640.2640.2640.26
Low39.5839.5325.0621.511.7721.5
Performance+4.09%-8.25%-0.43%+42.71%+54.14%-8.36%

Industry Analysis and Valuation

According to current financial data, CNTA stock's P/E (TTM) ratio is -24.30, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CNTA, including P/S (N/A), P/B (12.50), and P/FCF (-29.34), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationCNTASector MedianIndustry AvgS&P 500
P/E (TTM)-24.3-1.22-5.1232.59
P/S (TTM)N/A3.69464.325.98
P/B (TTM)12.51.1510.925.27
P/FCF (TTM)-29.34-6.79-912.1429.85

Frequently Asked Questions

How is CNTA price-to-earnings ratio currently?
CNTA has a current P/E ratio of -24.3
How are CNTA's price-to-sale and price-to-book ratios?
The CNTA stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 12.5.
Is Centessa Pharmaceuticals plc's price-to-cashflow ratio high or low?
CNTA's price-to-free-cashflow (P/FCF) ratio is -29.34, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for CNTA?
Based on CNTA's recent bid, its distance from 20 days simple moving average is 7.74%. It is 9.7% apart from 50 days simple moving average, and it is 30.29% apart from 200 days simple moving average.
What is the 52-week price range for CNTA?
The 52-week high for CNTA is $40.26 which is -12.46% away from the current price level whereas the distance of that from the 52-week low of $11.77 stands at 178.85%.
An overview of CNTA's stock performance: how did it fare?
The performance of CNTA stock was not encouraging with most of its significant price indicators in red. Centessa Pharmaceuticals plc(NASDAQ: CNTA) shares have moved downward -0.18% or - $0.07 in the latest trading session and have lost -8.36% year-to-date (YTD). The stock has gained nearly 54.14% over the past year. After moving -0.43% over the trailing 3-month period, the stock is 42.71% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 4.09% a week and -8.25% a month.
What is CNTA's 14-day relative strength index (RSI)?
The current 14-day RSI for CNTA stock is 65.54. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For CNTA, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Centessa Pharmaceuticals plc (CNTA) has a 14-day ATR of 1.23.
What is CNTA's current enterprise value?
After closing at $39.76 with 154.73M of its shares outstanding, the current enterprise value of CNTA is roughly 890.97M.
Over the past year, how has the stock price of CNTA changed?
Centessa Pharmaceuticals plc (NASDAQ: CNTA) is up 54.14% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 9.37%. CNTA stock price is also down -8.36% on its value in year-to-date trading.
What is the average trading volume for CNTA shares?
The number outstanding shares of CNTA is 154.73M, and of these 63.56% shares are freely available for trading. On average, CNTA stock has traded 1.66M shares per day for the past 10 days. A total of 1.78M shares changed hands during the last trading session with the average session volume of 2.59M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph